Biggest News Aggregation in the World
๐Ÿ“ฐ Patent News

Page 37 - Patent News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Patent. Real-time updates on events, politics, business and more.

Updates On Aflibercept BPCIA Litigation - Life Sciences, Biotechnology & Nanotechnology

On Friday, January 20, 2024, Regeneron Pharmaceuticals, Inc. ("Regeneron") filed an ex parte application for a scheduling order setting the schedule for preliminary injunction proceedings or, in the alternative, an emergency status conference.
United States Northern District West Virginia Samsung Bioepis Celltrion Inc Regeneron Pharmaceuticals Inc
Source: mondaq.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

USPTO Clarifies Guidance To Judicial Boards On Holding Parties Responsible For The Misuse Of AI In Legal Proceedings - Trademark

On February 6, 2024, USPTO Director Kathy Vidal issued guidance clarifying the existing rules regarding using Artificial Intelligence (AI) in the drafting of submissions to the Patent Trial...
Kathy Vidal Appeal Board Trademark Trial Uspto Clarifies Guidance To Judicial Boards On Holding Parties Responsible For The Misuse Of Ai In Legal Proceedings Intellectual Property
Source: mondaq.com

The Interplay Of IPRs And Litigation: Leveraging Inequitable Conduct Claims To Raise Prior Art In Litigation Despite IPR Estoppel Preventing Assertion Of The Same Prior Art In Invalidity Grounds - Patent

Plaintiff Cellwitch, Inc. ("Cellwitch"), filed a suit alleging that Defendant Tile, Inc. ("Tile") infringes U.S. Pat. No. 8,872,655 (the "'655 Patent").
Plaintiff Cellwitch Inc Defendant Tile Inc Plaintiff Cellwitch Defendant Tile Patent Trial Appeal Board
Source: mondaq.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science